FDA: New Rx Label Rules to Better Inform Pregnant Women

Share this content:
FDA: New Rx Label Rules to Better Inform Pregnant Women
FDA: New Rx Label Rules to Better Inform Pregnant Women

(HealthDay News) -- A new labeling system should give women and their doctors clearer information on the risks and benefits of prescription medicines when taken during pregnancy and breastfeeding, the U.S. Food and Drug Administration said Wednesday.

The new regulations are aimed at labels on prescription drugs and biological products, and will take effect for newly approved drugs beginning on June 30 of next year. Older drugs will have their labels changed more gradually, the FDA said.

Currently, drugs are labeled by a series of lettered categories -- A, B, C, D, and X -- that are used to classify the risk of using medicines during pregnancy and breastfeeding. Beginning next June, the lettered system will be replaced with three detailed subsections -- "Pregnancy," "Lactation," and "Females and Males of Reproductive Potential." The "Lactation" subsection on the new labels will provide more information on whether or not a medicine gets into breast milk and how that may or may not affect a breastfeeding infant. The "Females and Males of Reproductive Potential" subsection will also offer information about pregnancy testing, birth control, and how a medicine affects fertility, the FDA said.

It could take drug makers several years to make all the required label changes on older medications, according to the FDA.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »